title: Design of renin inhibitors containing conformationally restricted mimetics of the P1-P1' and P1 through P2' sites.
authors.affiliation: Merck, Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
authors.forename: P D
authors.initials: PD
authors.lastname: Williams
authors.forename: L S
authors.initials: LS
authors.lastname: Payne
authors.forename: D S
authors.initials: DS
authors.lastname: Perlow
authors.forename: M K
authors.initials: MK
authors.lastname: Holloway
authors.forename: P K
authors.initials: PK
authors.lastname: Siegl
authors.forename: T W
authors.initials: TW
authors.lastname: Schorn
authors.forename: R J
authors.initials: RJ
authors.lastname: Lynch
authors.forename: J J
authors.initials: JJ
authors.lastname: Doyle
authors.forename: J F
authors.initials: JF
authors.lastname: Strouse
authors.forename: G P
authors.initials: GP
authors.lastname: Vlasuk
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry; D011487:Protein Conformation; D012083:Renin / Q000737:chemistry; D000092502:Renin Inhibitors
chemical_list: D009842:Oligopeptides; D012083:Renin; D000092502:Renin Inhibitors; C051529:renin inhibitory peptide, 4-amino-5-cyclohexyl-3-hydroxypentanoic acid